Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_assertion type Assertion NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_head.
- NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_assertion description "[Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_provenance.
- NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_assertion evidence source_evidence_literature NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_provenance.
- NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_assertion SIO_000772 15128051 NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_provenance.
- NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_assertion wasDerivedFrom gad-20150221 NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_provenance.
- NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_assertion wasGeneratedBy ECO_0000203 NP142262.RA-Q48je7HCt4JsTmXBit3Iw94gK4Y4xZaPUf0PWv4ql4130_provenance.